• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无风团的特发性组胺能性血管性水肿:31例病例系列

Idiopathic histaminergic angioedema without wheals: a case series of 31 patients.

作者信息

Faisant C, Boccon-Gibod I, Mansard C, Dumestre Perard C, Pralong P, Chatain C, Deroux A, Bouillet L

机构信息

Department of Internal Medicine, Grenoble University Hospital.

Grenoble Alps University.

出版信息

Clin Exp Immunol. 2016 Jul;185(1):81-5. doi: 10.1111/cei.12789. Epub 2016 Apr 13.

DOI:10.1111/cei.12789
PMID:26969870
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4908297/
Abstract

Idiopathic histaminergic acquired angioedema (IH-AAE) is a common cause of recurrent angioedema without wheals. It is a mast cell-mediated disease thought to belong to the same clinical entity as chronic urticaria (CU). The objective of this study was to describe the clinical and epidemiological characteristics of IH-AAE patients. From 2014 to 2015, 534 patients were seen at our national reference centre for angioedema and/or urticaria. Among them, we identified 31 patients with idiopathic histaminergic acquired angioedema without wheals (IH-AAE). Thirty-one patients (15 men and 16 women) with a mean age of 50 years met the criteria for IH-AAE. The average delay in diagnosis was 6·3 years. A history of allergy was found in 12 patients (38·7%), nine suffering from allergic rhinitis. The mean duration of attacks was 28·1 h. The AE attack was located in the upper respiratory tract in 54·8% of cases (17 patients). A lingual location was found in 29% of patients. Men were more likely than women to have an upper airway involvement. No intubations or admissions to intensive care units were reported. The dosage of anti-histamines to control the symptoms was onefold the recommended dose in 51·6% of patients (16 patients), twofold in 32% (10 patients) and three-fourfold in 16·1% (five patients). IH-AAE is characterized by an important delay in diagnosis, a frequent involvement of the upper airway and a benign course during attacks. As in CU, a trial of up to fourfold dose of H1-anti-histamines may be necessary to control symptoms.

摘要

特发性组胺能获得性血管性水肿(IH - AAE)是反复出现无风团性血管性水肿的常见原因。它是一种肥大细胞介导的疾病,被认为与慢性荨麻疹(CU)属于同一临床实体。本研究的目的是描述IH - AAE患者的临床和流行病学特征。2014年至2015年期间,我们国家血管性水肿和/或荨麻疹参考中心共诊治了534例患者。其中,我们确定了31例患有特发性组胺能获得性无风团血管性水肿(IH - AAE)的患者。31例患者(15名男性和16名女性),平均年龄50岁,符合IH - AAE的标准。诊断的平均延迟时间为6.3年。12例患者(38.7%)有过敏史,其中9例患有过敏性鼻炎。发作的平均持续时间为28.1小时。54.8%的病例(17例患者)血管性水肿发作位于上呼吸道。29%的患者发现有舌部受累。男性比女性更易出现上气道受累。未报告有插管或入住重症监护病房的情况。51.6%的患者(16例)控制症状所需的抗组胺药剂量是推荐剂量的1倍,32%(10例)是2倍,16.1%(5例)是3至4倍。IH - AAE的特点是诊断延迟时间长、上气道频繁受累且发作期病程良性。与慢性荨麻疹一样,可能需要试用高达4倍剂量的H1抗组胺药来控制症状。

相似文献

1
Idiopathic histaminergic angioedema without wheals: a case series of 31 patients.无风团的特发性组胺能性血管性水肿:31例病例系列
Clin Exp Immunol. 2016 Jul;185(1):81-5. doi: 10.1111/cei.12789. Epub 2016 Apr 13.
2
[Histaminergic angioedema and chronic urticaria].[组胺能性血管性水肿与慢性荨麻疹]
Presse Med. 2015 Jan;44(1):37-42. doi: 10.1016/j.lpm.2014.11.001. Epub 2014 Dec 18.
3
Assessment of clinical phenotypic characteristics of patients with angioedema without wheals in a turkish population.评估土耳其人群中无风团性血管性水肿患者的临床表型特征。
Allergy Asthma Proc. 2024 Jul 1;45(4):240-246. doi: 10.2500/aap.2024.45.240034.
4
Angioedema without wheals: a clinical update.无风团性血管性水肿:临床更新。
Balkan Med J. 2021 Mar;38(2):73-81. doi: 10.5152/balkanmedj.2021.20060.
5
Epidemiology of angioedema without wheals in an allergy and immunology center.
Medicina (B Aires). 2015;75(5):273-6.
6
Recurrent Angioedema: Occurrence, Features, and Concomitant Diseases in an Italian Single-Center Study.复发性血管性水肿:一项意大利单中心研究中的发生率、特征及伴发疾病
Int Arch Allergy Immunol. 2017;172(1):55-63. doi: 10.1159/000453663. Epub 2017 Feb 22.
7
Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome Survey.获得性血管性水肿与遗传性血管性水肿(I/II型)的比较:依卡替班疗效调查结果
Clin Exp Immunol. 2017 Apr;188(1):148-153. doi: 10.1111/cei.12910. Epub 2017 Feb 9.
8
Urticaria and angioedema.荨麻疹和血管性水肿。
Med Clin North Am. 1992 Jul;76(4):805-40. doi: 10.1016/s0025-7125(16)30327-3.
9
[Angioedema and urticaria].[血管性水肿和荨麻疹]
Ann Dermatol Venereol. 2014 Nov;141 Suppl 3:S586-95. doi: 10.1016/S0151-9638(14)70162-0.
10
Characterization of patients with angioedema without wheals: the importance of F12 gene screening.无风团性血管性水肿患者的特征:F12基因筛查的重要性。
Clin Immunol. 2015 Apr;157(2):239-48. doi: 10.1016/j.clim.2015.02.013. Epub 2015 Mar 2.

引用本文的文献

1
Natural History of Pediatric Idiopathic Histaminergic Angioedema: A Retrospective Monocentric Study.儿童特发性组胺能性血管性水肿的自然病史:一项回顾性单中心研究
Children (Basel). 2025 May 4;12(5):600. doi: 10.3390/children12050600.
2
Predictive model to differentiate chronic histaminergic angioedema and chronic spontaneous urticaria with angioedema.用于鉴别慢性组胺能性血管性水肿和伴有血管性水肿的慢性自发性荨麻疹的预测模型。
J Allergy Clin Immunol Glob. 2024 May 9;3(3):100278. doi: 10.1016/j.jacig.2024.100278. eCollection 2024 Aug.
3
Clinical features and potential markers of disease in idiopathic non-histaminergic angioedema, a real-life study.特发性非组胺性血管性水肿的临床特征和潜在疾病标志物:一项真实世界研究。
Immunol Res. 2024 Oct;72(5):991-1002. doi: 10.1007/s12026-024-09501-9. Epub 2024 Jun 3.
4
Differences and Similarities in the Mechanisms and Clinical Expression of Bradykinin-Mediated vs. Mast Cell-Mediated Angioedema.缓激肽介导的血管性水肿与肥大细胞介导的血管性水肿在机制和临床表型方面的差异与相似之处。
Clin Rev Allergy Immunol. 2021 Aug;61(1):40-49. doi: 10.1007/s12016-021-08841-w. Epub 2021 Feb 3.
5
Idiopathic Angioedema: Current Challenges.特发性血管性水肿:当前面临的挑战
J Asthma Allergy. 2020 Apr 17;13:137-144. doi: 10.2147/JAA.S205709. eCollection 2020.
6
Idiopathic non-histaminergic acquired angioedema: a case series and discussion of published clinical trials.特发性非组胺能获得性血管性水肿:病例系列及已发表临床试验的讨论
Clin Transl Allergy. 2017 Aug 31;7:27. doi: 10.1186/s13601-017-0164-9. eCollection 2017.
7
Angioedema suppressed by a combination of anti-histamine and leukotriene modifier.血管性水肿通过抗组胺药和白三烯调节剂的联合使用得到抑制。
Allergy Asthma Clin Immunol. 2017 Jun 13;13:28. doi: 10.1186/s13223-017-0201-1. eCollection 2017.
8
Idiopathic Non-histaminergic Angioedema: Successful Treatment with Omalizumab in Five Patients.特发性非组胺能性血管性水肿:5例患者使用奥马珠单抗治疗成功
J Clin Immunol. 2017 Jan;37(1):80-84. doi: 10.1007/s10875-016-0345-7. Epub 2016 Nov 8.
9
Efficacy of Treatment of Non-hereditary Angioedema.非遗传性血管性水肿的治疗效果。
Clin Rev Allergy Immunol. 2018 Jun;54(3):412-431. doi: 10.1007/s12016-016-8585-0.

本文引用的文献

1
Gender-related differences in chronic urticaria.
G Ital Dermatol Venereol. 2016 Oct;151(5):544-52. Epub 2015 Jun 19.
2
Presentation, diagnosis and treatment of angioedema without wheals: a retrospective analysis of a cohort of 1058 patients.无风团性血管性水肿的表现、诊断和治疗:1058 例患者队列的回顾性分析。
J Intern Med. 2015 May;277(5):585-93. doi: 10.1111/joim.12304. Epub 2014 Sep 27.
3
The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update.变应性接触性皮炎诊断和治疗的欧洲指南(2013 年版)
Allergy. 2014 Jul;69(7):868-87. doi: 10.1111/all.12313. Epub 2014 Apr 30.
4
Recurrent angioedema: diagnosis strategy and biological aspects.复发性血管性水肿:诊断策略与生物学方面
Eur J Dermatol. 2014 May-Jun;24(3):293-6. doi: 10.1684/ejd.2014.2276.
5
Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group.血管性水肿的分类、诊断和治疗方法:遗传性血管性水肿国际工作组的共识报告。
Allergy. 2014 May;69(5):602-16. doi: 10.1111/all.12380. Epub 2014 Mar 27.
6
Angioedema.血管性水肿。
Immunol Allergy Clin North Am. 2014 Feb;34(1):23-31. doi: 10.1016/j.iac.2013.09.004. Epub 2013 Oct 20.
7
Corticosteroids should not be used in urticaria because of the potential risk of steroid dependence and development of severe anti-H1- resistant urticaria.由于存在类固醇依赖和严重抗H1耐药性荨麻疹发展的潜在风险,皮质类固醇不应被用于治疗荨麻疹。
Eur J Dermatol. 2011 May-Jun;21(3):431. doi: 10.1684/ejd.2011.1311.
8
Usefulness of a short course of oral prednisone in antihistamine-resistant chronic urticaria: a retrospective analysis.口服泼尼松短期疗程治疗抗组胺药抵抗性慢性荨麻疹的疗效:回顾性分析。
J Investig Allergol Clin Immunol. 2010;20(5):386-90.
9
The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria.左西替利嗪和地氯雷他定在常规剂量的 4 倍治疗难治性荨麻疹的疗效。
J Allergy Clin Immunol. 2010 Mar;125(3):676-82. doi: 10.1016/j.jaci.2009.11.047.
10
Angioedema.血管性水肿
J Am Acad Dermatol. 2005 Sep;53(3):373-88; quiz 389-92. doi: 10.1016/j.jaad.2004.09.032.